drugset / Trial / NCT03263117

SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke

NCT03263117

RandomizedParallel-groupSingle-blindTreatment

Summary

Objectives: This study aims to estimate overall treatment benefit (improvement in disability) among acute ischemic stroke patients that are randomized to General Anesthesia (GA) compared with Sedation (CS) during endovascular therapy. Assess safety (as measured by incidence of symptomatic intracranial hemorrhage); rates of Endovascular therapy (EVT) procedural complications, reperfusion; and quality of life. Hypothesis: GA during EVT for acute ischemic stroke improves functional outcomes at 90 days compared to sedation.

Timeline

Start
2018-07-01
Primary completion
2023-04-22
Completion
2023-04-22

Drugs

EvaluationDrugModalityDoseRoute
Comparator Desflurane Other / unclassified
Comparator Dexmedetomidine Other / unclassified
Comparator Etomidate Small molecule
Comparator Fentanyl Other / unclassified
Comparator Lidocaine Other / unclassified
Comparator Midazolam Small molecule
Comparator Propofol Small molecule Intravenous
Comparator Rocuronium Other / unclassified
Comparator Sevoflurane Other / unclassified
Comparator Suxamethonium Other / unclassified
Comparator Vecuronium Small molecule

Indications